[1]
Aroon Kumar, “MONITORING DIABETES PATIENTS RECEIVING TUBERCULOSIS THERAPY”, J Popl Ther Clin Pharmacol, vol. 31, no. 8, pp. 1875–1880, Aug. 2024, doi: 10.53555/ecm0x978.